The blogosphere is alive with the news that a federal court has overturned a patent held by Myriad Genetics for the BRCA1 and BRCA2 breast cancer genes. The company patented the genes in the 1990s and then invented a test to identify some of the mutations, according to the Los Angeles Times blog Booster Shots. "You might be asking yourself how a company could get a patent on a gene, which isn’t a man-made invention.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.